{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:55:26Z","timestamp":1783551326984,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160230, 82173678, 81773564"],"award-info":[{"award-number":["32160230, 82173678, 81773564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"Talent Innovation and Entrepreneurship Project in Chengguan District, Lanzhou , Gansu Province","award":["2022RCCX0024"],"award-info":[{"award-number":["2022RCCX0024"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]},{"name":"1st Hospital of Lanzhou University Scientifc Research Foundation","award":["ldyyyn2019-03"],"award-info":[{"award-number":["ldyyyn2019-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06127-1","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:42:53Z","timestamp":1751406173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Xuekai","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingman","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"Suppl 1","key":"6127_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan, S. A., Tavolari, S., Brandi, G. & Cholangiocarcinoma Epidemiology and risk factors. Liver International: Official J. Int. Association Study Liver. 39 (Suppl 1), 19\u201331. https:\/\/doi.org\/10.1111\/liv.14095 (2019).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"6127_CR2","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ejso.2020.01.028","volume":"46","author":"N Machairas","year":"2020","unstructured":"Machairas, N., Lang, H., Jayant, K., Raptis, D. A. & Sotiropoulos, G. C. Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives. Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol. 46, 740\u2013746. https:\/\/doi.org\/10.1016\/j.ejso.2020.01.028 (2020).","journal-title":"Eur. J. Surg. Oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol."},{"key":"6127_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6127_CR4","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. Cancer J. Clin. 73, 198\u2013222. https:\/\/doi.org\/10.3322\/caac.21759 (2023).","journal-title":"Cancer J. Clin."},{"key":"6127_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14728222.2020.1733528","volume":"24","author":"K Sato","year":"2020","unstructured":"Sato, K. et al. Cholangiocarcinoma: novel therapeutic targets. Expert Opin. Ther. Targets. 24, 345\u2013357. https:\/\/doi.org\/10.1080\/14728222.2020.1733528 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"key":"6127_CR6","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corr\u00f2","year":"2020","unstructured":"Corr\u00f2, C., Novellasdemunt, L. & Li, V. S. W. A brief history of organoids. Am. J. Physiol. Cell Physiol. 319, C151\u2013c165. https:\/\/doi.org\/10.1152\/ajpcell.00120.2020 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"6127_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12967-020-02677-2","volume":"19","author":"L Liu","year":"2021","unstructured":"Liu, L., Yu, L., Li, Z., Li, W. & Huang, W. Patient-derived organoid (PDO) platforms to facilitate clinical decision making. J. Translational Med. 19, 40. https:\/\/doi.org\/10.1186\/s12967-020-02677-2 (2021).","journal-title":"J. Translational Med."},{"key":"6127_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2014.05.002","volume":"351","author":"D Wu","year":"2014","unstructured":"Wu, D. et al. Peptide-based cancer therapy: opportunity and challenge. Cancer Lett. 351, 13\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2014.05.002 (2014).","journal-title":"Cancer Lett."},{"key":"6127_CR9","doi-asserted-by":"crossref","unstructured":"Qi, Y. K., Zheng, J. S. & Liu, L. Mirror-image protein and peptide drug discovery through mirror-image phage display. Chem (2024).","DOI":"10.1016\/j.chempr.2024.06.004"},{"key":"6127_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","volume":"57","author":"W Chiangjong","year":"2020","unstructured":"Chiangjong, W., Chutipongtanate, S. & Hongeng, S. Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review). Int. J. Oncol. 57, 678\u2013696. https:\/\/doi.org\/10.3892\/ijo.2020.5099 (2020).","journal-title":"Int. J. Oncol."},{"key":"6127_CR11","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1021\/acs.jmedchem.3c02232","volume":"67","author":"XY Fu","year":"2024","unstructured":"Fu, X. Y. et al. Three rounds of stability-guided optimization and systematical evaluation of oncolytic peptide LTX-315. J. Med. Chem. 67, 3885\u20133908 (2024).","journal-title":"J. Med. Chem."},{"key":"6127_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41401-022-00939-x","volume":"44","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. Acta Pharmacol. Sin. 44, 201\u2013210 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"6127_CR13","doi-asserted-by":"publisher","first-page":"106674","DOI":"10.1016\/j.bioorg.2023.106674","volume":"138","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates. Bioorg. Chem. 138, 106674 (2023).","journal-title":"Bioorg. Chem."},{"key":"6127_CR14","doi-asserted-by":"publisher","first-page":"200004","DOI":"10.1098\/rsob.200004","volume":"10","author":"M Xie","year":"2020","unstructured":"Xie, M., Liu, D. & Yang, Y. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open. Biology. 10, 200004. https:\/\/doi.org\/10.1098\/rsob.200004 (2020).","journal-title":"Open. Biology"},{"key":"6127_CR15","doi-asserted-by":"publisher","unstructured":"Wu, X. et al. Rational design of a new short anticancer peptide with good potential for cancer treatment. Eur. J. Med. Chem. 273 https:\/\/doi.org\/10.1016\/j.ejmech.2024.116519 (2024).","DOI":"10.1016\/j.ejmech.2024.116519"},{"key":"6127_CR16","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1021\/acs.jnatprod.1c00963","volume":"84","author":"J Chai","year":"2021","unstructured":"Chai, J. et al. Antitumor effects of Scorpion peptide Smp43 through mitochondrial dysfunction and membrane disruption on hepatocellular carcinoma. J. Nat. Prod. 84, 3147\u20133160. https:\/\/doi.org\/10.1021\/acs.jnatprod.1c00963 (2021).","journal-title":"J. Nat. Prod."},{"key":"6127_CR17","doi-asserted-by":"publisher","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat. Reviews Disease Primers. 2 https:\/\/doi.org\/10.1038\/nrdp.2016.18 (2016).","DOI":"10.1038\/nrdp.2016.18"},{"key":"6127_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435. https:\/\/doi.org\/10.1038\/nm.4438 (2017).","journal-title":"Nat. Med."},{"key":"6127_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.celrep.2019.03.088","volume":"27","author":"Y Saito","year":"2019","unstructured":"Saito, Y. et al. Establishment of Patient-Derived organoids and drug screening for biliary tract carcinoma. Cell. Rep. 27, 1265\u20131276e1264. https:\/\/doi.org\/10.1016\/j.celrep.2019.03.088 (2019).","journal-title":"Cell. Rep."},{"key":"6127_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jss.2014.05.017","volume":"192","author":"L Sulpice","year":"2014","unstructured":"Sulpice, L. et al. Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma. J. Surg. Res. 192, 117\u2013123. https:\/\/doi.org\/10.1016\/j.jss.2014.05.017 (2014).","journal-title":"J. Surg. Res."},{"key":"6127_CR21","doi-asserted-by":"publisher","first-page":"81367","DOI":"10.18632\/oncotarget.13229","volume":"7","author":"P Wang","year":"2016","unstructured":"Wang, P. & Lv, L. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach. Oncotarget 7, 81367\u201381376. https:\/\/doi.org\/10.18632\/oncotarget.13229 (2016).","journal-title":"Oncotarget"},{"key":"6127_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","volume":"42","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer. Cancer Cell. 42, 535\u2013551e538. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.004 (2024).","journal-title":"Cancer Cell."},{"key":"6127_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.semcdb.2022.09.005","volume":"144","author":"AC Debruyne","year":"2023","unstructured":"Debruyne, A. C., Okkelman, I. A. & Dmitriev, R. I. Balance between the cell viability and death in 3D. Semin. Cell Dev. Biol. 144, 55\u201366. https:\/\/doi.org\/10.1016\/j.semcdb.2022.09.005 (2023).","journal-title":"Semin. Cell Dev. Biol."},{"key":"6127_CR24","doi-asserted-by":"publisher","unstructured":"Wang, Z. et al. Establishment and drug screening of patient-derived extrahepatic biliary tract carcinoma organoids. Cancer Cell Int. 21 https:\/\/doi.org\/10.1186\/s12935-021-02219-w (2021).","DOI":"10.1186\/s12935-021-02219-w"},{"key":"6127_CR25","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1111\/liv.16015","volume":"44","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Integrative analysis reveals different feature of intrahepatic cholangiocarcinoma subtypes. Liver International: Official J. Int. Association Study Liver. 44, 2477\u20132493. https:\/\/doi.org\/10.1111\/liv.16015 (2024).","journal-title":"Liver International: Official J. Int. Association Study Liver"},{"key":"6127_CR26","doi-asserted-by":"publisher","unstructured":"Wang, Y. et al. Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses. Front. Pharmacol. 15 https:\/\/doi.org\/10.3389\/fphar.2024.1416295 (2024).","DOI":"10.3389\/fphar.2024.1416295"},{"key":"6127_CR27","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1158\/0008-5472.Can-21-1538","volume":"81","author":"S Liang","year":"2021","unstructured":"Liang, S. et al. A PLCB1-PI3K-AKT signaling Axis activates EMT to promote cholangiocarcinoma progression. Cancer Res. 81, 5889\u20135903. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1538 (2021).","journal-title":"Cancer Res."},{"key":"6127_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41417-024-00754-y","volume":"31","author":"F Yuan","year":"2024","unstructured":"Yuan, F. et al. Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK\/eIF2\u03b1 pathway. Cancer Gene Ther. 31, 904\u2013916. https:\/\/doi.org\/10.1038\/s41417-024-00754-y (2024).","journal-title":"Cancer Gene Ther."},{"key":"6127_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-024-03370-w","volume":"24","author":"G Long","year":"2024","unstructured":"Long, G., Wang, D., Tang, J., Hu, K. & Zhou, L. USP8 promotes the tumorigenesis of intrahepatic cholangiocarcinoma via stabilizing OGT. Cancer Cell Int. 24, 238. https:\/\/doi.org\/10.1186\/s12935-024-03370-w (2024).","journal-title":"Cancer Cell Int."},{"key":"6127_CR30","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","volume":"127","author":"D Konishi","year":"2022","unstructured":"Konishi, D. et al. Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma. Br. J. Cancer. 127, 757\u2013765. https:\/\/doi.org\/10.1038\/s41416-022-01838-y (2022).","journal-title":"Br. J. Cancer"},{"key":"6127_CR31","doi-asserted-by":"publisher","first-page":"e37361","DOI":"10.1016\/j.heliyon.2024.e37361","volume":"10","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. The COL7A1\/PI3K\/AKT axis regulates the progression of cholangiocarcinoma. Heliyon 10, e37361. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37361 (2024).","journal-title":"Heliyon"},{"key":"6127_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13148-023-01592-9","volume":"15","author":"G Wu","year":"2023","unstructured":"Wu, G. et al. Upregulation of RSPO3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma. Clin. Epigenetics. 15, 177. https:\/\/doi.org\/10.1186\/s13148-023-01592-9 (2023).","journal-title":"Clin. Epigenetics"},{"key":"6127_CR33","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s41467-018-03276-y","volume":"9","author":"A Wang","year":"2018","unstructured":"Wang, A. et al. Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. Nat. Commun. 9, 894. https:\/\/doi.org\/10.1038\/s41467-018-03276-y (2018).","journal-title":"Nat. Commun."},{"key":"6127_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/s1470-2045(20)30157-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa, G. K. et al. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. Lancet Oncol. 21, 796\u2013807. https:\/\/doi.org\/10.1016\/s1470-2045(20)30157-1 (2020).","journal-title":"Lancet Oncol."},{"key":"6127_CR35","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","volume":"15","author":"E Driehuis","year":"2020","unstructured":"Driehuis, E., Kretzschmar, K. & Clevers, H. Establishment of patient-derived cancer organoids for drug-screening applications. Nat. Protoc. 15, 3380\u20133409. https:\/\/doi.org\/10.1038\/s41596-020-0379-4 (2020).","journal-title":"Nat. Protoc."},{"key":"6127_CR36","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tibtech.2017.12.005","volume":"36","author":"H Aboulkheyr Es","year":"2018","unstructured":"Aboulkheyr Es, H., Montazeri, L., Aref, A. R., Vosough, M. & Baharvand, H. Personalized Cancer medicine: an organoid approach. Trends Biotechnol. 36, 358\u2013371. https:\/\/doi.org\/10.1016\/j.tibtech.2017.12.005 (2018).","journal-title":"Trends Biotechnol."},{"key":"6127_CR37","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1111\/jgh.15930","volume":"37","author":"X Ren","year":"2022","unstructured":"Ren, X., Chen, W., Yang, Q., Li, X. & Xu, L. Patient-derived cancer organoids for drug screening: basic technology and clinical application. J. Gastroenterol. Hepatol. 37, 1446\u20131454. https:\/\/doi.org\/10.1111\/jgh.15930 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"6127_CR38","doi-asserted-by":"publisher","first-page":"114996","DOI":"10.1016\/j.biopha.2023.114996","volume":"164","author":"RK Chinnadurai","year":"2023","unstructured":"Chinnadurai, R. K. et al. Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications. Biomed. pharmacotherapy = Biomedecine Pharmacotherapie. 164, 114996. https:\/\/doi.org\/10.1016\/j.biopha.2023.114996 (2023).","journal-title":"Biomed. pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"6127_CR39","doi-asserted-by":"publisher","first-page":"102153","DOI":"10.1016\/j.ceb.2023.102153","volume":"80","author":"EA Morales","year":"2023","unstructured":"Morales, E. A., Gaeta, I. & Tyska, M. J. Building the brush border, one Microvillus at a time. Curr. Opin. Cell Biol. 80, 102153. https:\/\/doi.org\/10.1016\/j.ceb.2023.102153 (2023).","journal-title":"Curr. Opin. Cell Biol."},{"key":"6127_CR40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev.physiol.69.040705.141236","volume":"69","author":"P Satir","year":"2007","unstructured":"Satir, P. & Christensen, S. T. Overview of structure and function of mammalian cilia. Annu. Rev. Physiol. 69, 377\u2013400. https:\/\/doi.org\/10.1146\/annurev.physiol.69.040705.141236 (2007).","journal-title":"Annu. Rev. Physiol."},{"key":"6127_CR41","doi-asserted-by":"publisher","unstructured":"Li, C. M. et al. Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells 10, (2021). https:\/\/doi.org\/10.3390\/cells10112908","DOI":"10.3390\/cells10112908"},{"key":"6127_CR42","doi-asserted-by":"publisher","unstructured":"Norouzi, P., Mirmohammadi, M. & Houshdar Tehrani, M. H. Anticancer peptides mechanisms, simple and complex. Chemico-Biol. Interact. 368 https:\/\/doi.org\/10.1016\/j.cbi.2022.110194 (2022).","DOI":"10.1016\/j.cbi.2022.110194"},{"key":"6127_CR43","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1007\/s00018-017-2604-z","volume":"74","author":"AA Baxter","year":"2017","unstructured":"Baxter, A. A., Lay, F. T., Poon, I. K. H., Kvansakul, M. & Hulett, M. D. Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects. Cell. Mol. Life Sci. 74, 3809\u20133825. https:\/\/doi.org\/10.1007\/s00018-017-2604-z (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"6127_CR44","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1038\/srep02984","volume":"3","author":"A Tyagi","year":"2013","unstructured":"Tyagi, A. et al. In Silico models for designing and discovering novel anticancer peptides. Sci. Rep. 3, 2984. https:\/\/doi.org\/10.1038\/srep02984 (2013).","journal-title":"Sci. Rep."},{"key":"6127_CR45","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31772","volume":"74","author":"J Shiota","year":"2021","unstructured":"Shiota, J., Samuelson, L. C. & Razumilava, N. Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet?? Hepatol. (Baltimore Md). 74, 2251\u20132263. https:\/\/doi.org\/10.1002\/hep.31772 (2021).","journal-title":"Hepatol. (Baltimore Md)"},{"key":"6127_CR46","doi-asserted-by":"publisher","unstructured":"Zhao, Y. et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8, e2003897, (2021). https:\/\/doi.org\/10.1002\/advs.202003897","DOI":"10.1002\/advs.202003897"},{"key":"6127_CR47","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ccell.2022.02.001","volume":"40","author":"GS van Tienderen","year":"2022","unstructured":"van Tienderen, G. S. et al. Hepatobiliary tumor organoids for personalized medicine: a multicenter view on establishment, limitations, and future directions. Cancer Cell. 40, 226\u2013230. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.001 (2022).","journal-title":"Cancer Cell."},{"key":"6127_CR48","doi-asserted-by":"publisher","first-page":"1105454","DOI":"10.3389\/fonc.2022.1105454","volume":"12","author":"C Xie","year":"2022","unstructured":"Xie, C. et al. Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening. Front. Oncol. 12, 1105454. https:\/\/doi.org\/10.3389\/fonc.2022.1105454 (2022).","journal-title":"Front. Oncol."},{"key":"6127_CR49","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ccell.2021.07.020","volume":"39","author":"V Veninga","year":"2021","unstructured":"Veninga, V. & Voest, E. E. Tumor organoids: opportunities and challenges to guide precision medicine. Cancer Cell. 39, 1190\u20131201. https:\/\/doi.org\/10.1016\/j.ccell.2021.07.020 (2021).","journal-title":"Cancer Cell."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06127-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T21:42:55Z","timestamp":1751406175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6127"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06127-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.17.638575","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Lanzhou University First Hospital, Gansu, China (Approval number: LDYYLL2024-788).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical declarations"}}],"article-number":"22870"}}